Latanoprostene Bunod 0.024% Early Experience Program (LEEP): A Canadian Initiative for Open-Angle Glaucoma and Ocular Hypertension by David Yan, Cindy M. L. Hutnik, Paul Harasymowycz

Get full text

When Is Evidence Enough Evidence? A Systematic Review and Meta-Analysis of the Trabectome as a Solo Procedure in Patients with Primary Open-Angle Glaucoma by Jeffrey T. Y. Chow, Cindy M. L. Hutnik, Karla Solo, Monali S. Malvankar-Mehta

Get full text

The effectiveness of antibiotic additives in irrigation fluid used during cataract surgery: A systematic review by Brian Edward Yu, William Herspiegel, Robert Khatib, Jeffrey Thevaranjan, Abbie Lai, Amit X. Garg, Cindy M.L. Hutnik, Monali Malvankar-Mehta

Get full text

Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review by W. Daniel Stamer, Thomas Chiu, Da-Wen Lu, Tsing Hong Wang, Prin Rojanapongpun, Ngamkae Ruangvaravate, Youn Hye Jo, Marlene R. Moster, Marlene R. Moster, Murray Fingeret, Nora Lee Cothran, Jessica Steen, Ian Benjamin Gaddie, Ömür Uçakhan-Gündüz, Wesam Shamseldin Shalaby, Wesam Shamseldin Shalaby, Cindy M. L. Hutnik

Get full text